Tuesday, 02 January 2024 12:17 GMT

Advanced Instruments Releases The Osmopro® MAX Automated Osmometer To Enhance Clinical Lab Productivity


(MENAFN- PR Newswire) The OsmoPRO MAX goes beyond providing accurate and precise test results to deliver a complete solution that simplifies the osmolality testing workflow. The instrument delivers increased efficiency through direct sampling from primary tubes without transfer to sample cups, automated barcode scanning to reduce transcription errors, and the capability to upload data to the AdvancedQC peer group program for Advanced Instruments' Protinol® and Renol® matrix-based controls.

Like all Advanced Instruments osmometers, the OsmoPRO MAX uses the industry-preferred freezing point depression method to deliver reliable osmolality results in minutes. The instrument is automatically cleaned with system fluid after each test to minimize the need for user intervention. New samples can be loaded continuously as they arrive, eliminating the need for batch testing.

"The OsmoPRO MAX delivers the usability, automation, and data management features sought by today's clinical laboratories," said Byron Selman, CEO of Advanced Instruments. "Advanced Instruments continues to innovate in the field of osmometry while remaining committed to the product quality and reliability that customers have experienced with our osmometers for the past 70 years."

About Advanced Instruments

Advanced Instruments, LLC, is a leading supplier of instrumentation for clinical, pharmaceutical, biotechnology, microbiology, and food laboratories around the world. Quality, reliability, service and support have been the company's guiding principles since our founding in 1955. Our innovative application of technology helps healthcare organizations improve the quality of care and industrial companies enhance quality and productivity. For more information, please visit aicompanies.

Media Contact:

Jon Flasher, Clinical Product Manager

[email protected]

Photo -
Logo -

MENAFN27012025003732001241ID1109133642



PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search